Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Prediction of One-Year Mortality Based upon A New Staged Mortality Risk Model in Patients with Aortic Stenosis Undergoing Transcatheter Valve Replacement.

Veulemans V, Polzin A, Maier O, Klein K, Wolff G, Hellhammer K, Afzal S, Piayda K, Jung C, Westenfeld R, Blehm A, Lichtenberg A, Kelm M, Zeus T.

J Clin Med. 2019 Oct 8;8(10). pii: E1642. doi: 10.3390/jcm8101642.

2.

Routine Glycoprotein IIb/IIIa Inhibitor Therapy in ST-Segment Elevation Myocardial Infarction: A Meta-analysis.

Karathanos A, Lin Y, Dannenberg L, Parco C, Schulze V, Brockmeyer M, Jung C, Heinen Y, Perings S, Zeymer U, Kelm M, Polzin A, Wolff G.

Can J Cardiol. 2019 May 7. pii: S0828-282X(19)30302-2. doi: 10.1016/j.cjca.2019.05.003. [Epub ahead of print] Review.

PMID:
31542257
3.

DAPT Cessation and MACE in Elderly Patients: What Is the Optimal Regimen and Duration?

Dannenberg L, Hohlfeld T, Zeus T, Kelm M, Polzin A.

JACC Cardiovasc Interv. 2019 Aug 26;12(16):1626-1627. doi: 10.1016/j.jcin.2019.06.014. No abstract available.

PMID:
31439344
4.

Integrin ß1 polymorphisms and bleeding risk after coronary artery stenting.

Thienel M, Lüsebrink E, Kastrati A, Dannenberg L, Polzin A, Schulz C, Massberg S, Petzold T.

Mol Biol Rep. 2019 Jul 29. doi: 10.1007/s11033-019-05003-2. [Epub ahead of print]

PMID:
31359383
5.

Oral Anticoagulation Therapy and Progression of Calcific Aortic Valve Stenosis: Factor Xa versus Factor IIa Inhibition?

Dannenberg L, Zako S, Mourikis P, Veulemans V, Kelm M, Zeus T, Polzin A.

Pharmacology. 2019;104(3-4):212-214. doi: 10.1159/000500821. Epub 2019 Jun 11. No abstract available.

6.

HALT in TAVR: What About Aspirin?

Polzin A, Veulemans V, Dannenberg L, Kelm M, Zeus T.

JACC Cardiovasc Interv. 2019 May 13;12(9):894. doi: 10.1016/j.jcin.2019.01.241. No abstract available.

PMID:
31072512
7.

The REAC-TAVI Trial: Is There a Need for More Potent Antithrombotic Strategy in TAVR?

Polzin A, Veulemans V, Dannenberg L, Kelm M, Zeus T.

JACC Cardiovasc Interv. 2019 Apr 22;12(8):802-803. doi: 10.1016/j.jcin.2019.02.004. No abstract available.

PMID:
31000021
8.

Kidney function stratified outcomes of percutaneous left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk.

Brockmeyer M, Wolff G, Krieger T, Lin Y, Karathanos A, Afzal S, Zeus T, Westenfeld R, Polzin A, Heinen Y, Perings S, Kelm M, Schulze V.

Acta Cardiol. 2019 Apr 14:1-9. doi: 10.1080/00015385.2019.1585643. [Epub ahead of print]

PMID:
30983505
9.

Cardioprotection by very mild hypothermia in mice.

Knoop B, Naguib D, Dannenberg L, Helten C, Zako S, Jung C, Levkau B, Grandoch M, Kelm M, Zeus T, Polzin A.

Cardiovasc Diagn Ther. 2019 Feb;9(1):64-67. doi: 10.21037/cdt.2018.08.07.

10.

Cost-comparison of third generation transcatheter aortic valve implantation (TAVI) devices in the German Health Care System.

Veulemans V, Piayda K, Afzal S, Polzin A, Quast C, Jung C, Westenfeld R, Zeus T, Kelm M, Hellhammer K.

Int J Cardiol. 2019 Mar 1;278:40-45. doi: 10.1016/j.ijcard.2018.12.007. Epub 2018 Dec 4.

11.

Balloon Valvuloplasty Followed by Transcatheter Aortic Valve Implantation as a Staged Procedure in Patients With Low-Flow Low-Gradient Aortic Stenosis.

Piayda K, Wimmer AC, Veulemans V, Afzal S, Sievert H, Gafoor S, Erkens R, Polzin A, Quast C, Jung C, Westenfeld R, Kelm M, Hellhammer K, Zeus T.

J Invasive Cardiol. 2018 Dec;30(12):437-442.

12.

Antiplatelet effects of aspirin and clopidogrel after left atrial appendage (LAA) occluder implantation.

Dannenberg L, Mourikis P, Naguib D, Zako S, Helten C, M'Pembele R, Trojovsky K, Konsek D, Wolff G, Brockmeyer M, Schulze V, Levkau B, Hohlfeld T, Zeus T, Kelm M, Polzin A.

Int J Cardiol. 2019 Jan 15;275:95-100. doi: 10.1016/j.ijcard.2018.10.040. Epub 2018 Oct 16.

PMID:
30509374
13.

The Latest Evolution of the Medtronic CoreValve System in the Era of Transcatheter Aortic Valve Replacement: Matched Comparison of the Evolut PRO and Evolut R.

Hellhammer K, Piayda K, Afzal S, Kleinebrecht L, Makosch M, Hennig I, Quast C, Jung C, Polzin A, Westenfeld R, Kelm M, Zeus T, Veulemans V.

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2314-2322. doi: 10.1016/j.jcin.2018.07.023.

PMID:
30466830
14.

Platelet Reactivity in Patients on Aspirin and Clopidogrel Therapy Measured by a New Bedside Whole-Blood Assay.

Polzin A, Helten C, Dannenberg L, Mourikis P, Naguib D, Achilles A, Knoop B, Zako S, Rehder S, Görlinger K, Levkau B, Zeus T, Kelm M, Hohlfeld T, Hoffmann T.

J Cardiovasc Pharmacol. 2019 Jan;73(1):40-47. doi: 10.1097/FJC.0000000000000631.

PMID:
30383606
15.

Malondialdehyde Assay in the Evaluation of Aspirin Antiplatelet Effects.

Polzin A, Dannenberg L, Schneider T, Knoop B, Naguib D, Helten C, Pöhl M, Kelm M, Zeus T, Hohlfeld T.

Pharmacology. 2019;103(1-2):23-29. doi: 10.1159/000493754. Epub 2018 Oct 24.

PMID:
30355919
16.

Non-vitamin K oral anticoagulants (NOAC) and the risk of myocardial infarction: Differences between factor IIa and factor Xa inhibition?

Polzin A, Dannenberg L, Wolff G, Helten C, Achilles A, Hohlfeld T, Zeus T, Kelm M, Massberg S, Petzold T.

Pharmacol Ther. 2019 Mar;195:1-4. doi: 10.1016/j.pharmthera.2018.10.005. Epub 2018 Oct 12. Review.

PMID:
30321554
17.

Dose reduction, oral application, and order of intake to preserve aspirin antiplatelet effects in dipyrone co-medicated chronic artery disease patients.

Dannenberg L, Petzold T, Achilles A, Naguib D, Zako S, Helten C, M'Pembele R, Mourikis P, Podsvyadek Y, Grandoch M, Levkau B, Zeus T, Kelm M, Hohlfeld T, Polzin A.

Eur J Clin Pharmacol. 2019 Jan;75(1):13-20. doi: 10.1007/s00228-018-2560-z. Epub 2018 Sep 24.

PMID:
30251061
18.

Safety and efficacy of Tirofiban in STEMI-patients.

Dannenberg L, Wolff G, Naguib D, Pöhl M, Zako S, Helten C, Mourikis P, Levkau B, Hohlfeld T, Zeus T, Kelm M, Schulze V, Polzin A.

Int J Cardiol. 2019 Jan 1;274:35-39. doi: 10.1016/j.ijcard.2018.09.052. Epub 2018 Sep 13.

PMID:
30236502
19.

Increased risk of myocardial infarction with dabigatran etexilate: Fact or fiction? A critical meta-analysis from integrating randomized controlled trials and real-world studies: Wine or spritzer?

Polzin A, Dannenberg L, Wolff G, Zeus T, Kelm M, Petzold T.

Int J Cardiol. 2018 Nov 1;270:82. doi: 10.1016/j.ijcard.2018.07.020. No abstract available.

PMID:
30219540
20.

Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy.

Keul P, Polzin A, Kaiser K, Gräler M, Dannenberg L, Daum G, Heusch G, Levkau B.

FASEB J. 2019 Jan;33(1):1482-1495. doi: 10.1096/fj.201801245R. Epub 2018 Aug 21.

PMID:
30130432
21.

Dynamic coronary roadmapping during percutaneous coronary intervention: a feasibility study.

Piayda K, Kleinebrecht L, Afzal S, Bullens R, Ter Horst I, Polzin A, Veulemans V, Dannenberg L, Wimmer AC, Jung C, Bönner F, Kelm M, Hellhammer K, Zeus T.

Eur J Med Res. 2018 Jul 31;23(1):36. doi: 10.1186/s40001-018-0333-x.

22.

[Update ESC-Guideline 2017: Dual Antiplatelet Therapy].

Massberg S, Polzin A.

Dtsch Med Wochenschr. 2018 Aug;143(15):1090-1093. doi: 10.1055/a-0549-8230. Epub 2018 Jul 30. German.

PMID:
30060279
23.

Safety and Efficacy in Prasugrel- Versus Ticagrelor-Treated Patients With ST-Elevation Myocardial Infarction.

Dimitroulis D, Golabkesh M, Naguib D, Knoop B, Dannenberg L, Helten C, Pöhl M, Jung C, Kelm M, Zeus T, Polzin A.

J Cardiovasc Pharmacol. 2018 Oct;72(4):186-190. doi: 10.1097/FJC.0000000000000609.

PMID:
29985284
24.

Current and future aspects of multimodal and fusion imaging in structural and coronary heart disease.

Veulemans V, Hellhammer K, Polzin A, Bönner F, Zeus T, Kelm M.

Clin Res Cardiol. 2018 Aug;107(Suppl 2):49-54. doi: 10.1007/s00392-018-1284-5. Epub 2018 Jun 12. Review.

PMID:
29948289
25.

Major adverse cardiac events and drug-coated balloon size in coronary interventions.

Naguib D, Knoop B, Dannenberg L, Liebsch E, Pöhl M, Helten C, Assadi-Schmidt A, Kelm M, Zeus T, Polzin A.

Anatol J Cardiol. 2018 Jun;19(6):382-387. doi: 10.14744/AnatolJCardiol.2018.67864.

26.

Fusion Imaging During the Interventional Closure of Patent Foramen Ovale and Atrial Septal Defects: Mandatory or Superfluous?

Afzal S, Veulemans V, Kleinebrecht L, Stuewe D, Balzer J, Polzin A, Nijhof N, Kelm M, Zeus T, Hellhammer K.

JACC Cardiovasc Imaging. 2018 Oct;11(10):1543-1545. doi: 10.1016/j.jcmg.2018.01.007. Epub 2018 Apr 18. No abstract available.

27.

Perioperative aspirin therapy in non-cardiac surgery: A systematic review and meta-analysis of randomized controlled trials.

Wolff G, Navarese EP, Brockmeyer M, Lin Y, Karathanos A, Kołodziejczak M, Kubica J, Polzin A, Zeus T, Westenfeld R, Andreotti F, Kelm M, Schulze V.

Int J Cardiol. 2018 May 1;258:59-67. doi: 10.1016/j.ijcard.2017.12.088. Review. No abstract available.

PMID:
29544957
28.

Subclinical leaflet thrombosis.

Piayda K, Zeus T, Sievert H, Kelm M, Polzin A.

Lancet. 2018 Mar 10;391(10124):937-938. doi: 10.1016/S0140-6736(18)30534-8. No abstract available.

PMID:
29536857
29.

Platelet function testing: dead or alive.

Helten C, Naguib D, Dannenberg L, Pöhl M, Ayhan A, Hohlfeld T, Levkau B, Kelm M, Zeus T, Polzin A.

J Thromb Haemost. 2018 May;16(5):984-986. doi: 10.1111/jth.13997. Epub 2018 Apr 2.

PMID:
29512292
30.

Patent foramen ovale closure or medical therapy for cryptogenic ischemic stroke: an updated meta-analysis of randomized controlled trials.

Schulze V, Lin Y, Karathanos A, Brockmeyer M, Zeus T, Polzin A, Perings S, Kelm M, Wolff G.

Clin Res Cardiol. 2018 Sep;107(9):745-755. doi: 10.1007/s00392-018-1224-4. Epub 2018 Mar 2. Review.

PMID:
29500568
31.

Aspirin Inhibits Platelet-Derived Sphingosine-1-Phosphate Induced Endothelial Cell Migration.

Polzin A, Knoop B, Böhm A, Dannenberg L, Zurek M, Zeus T, Kelm M, Levkau B, Rauch BH.

Pharmacology. 2018;101(1-2):72-75. doi: 10.1159/000484208. Epub 2017 Oct 31.

PMID:
29131082
32.

Pharmacosimulation of interruptions and its solution in intravenous administration of cangrelor.

Masyuk M, Heramvand N, Muessig JM, Nia AM, Polzin A, Kollmann M, Kelm M, Jung C.

Clin Hemorheol Microcirc. 2018;68(4):421-425. doi: 10.3233/CH-170323.

PMID:
29036802
33.

Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve.

Piayda K, Mohring A, Dannenberg L, Gafoor S, Sievert H, Kelm M, Zeus T, Polzin A.

JACC Cardiovasc Interv. 2017 Aug 14;10(15):1598-1599. doi: 10.1016/j.jcin.2017.05.060. No abstract available.

34.

Cardiovascular Magnetic Resonance Relaxometry Predicts Regional Functional Outcome After Experimental Myocardial Infarction.

Haberkorn SM, Jacoby C, Ding Z, Keul P, Bönner F, Polzin A, Levkau B, Schrader J, Kelm M, Flögel U.

Circ Cardiovasc Imaging. 2017 Aug;10(8). pii: e006025. doi: 10.1161/CIRCIMAGING.116.006025.

PMID:
28790121
35.

Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease.

Polzin A, Piayda K, Keul P, Dannenberg L, Mohring A, Gräler M, Zeus T, Kelm M, Levkau B.

J Mol Cell Cardiol. 2017 Sep;110:35-37. doi: 10.1016/j.yjmcc.2017.07.004. Epub 2017 Jul 12.

PMID:
28709768
36.

Thromboxane Formation Assay to Identify High On-Treatment Platelet Reactivity to Aspirin.

Mohring A, Piayda K, Dannenberg L, Zako S, Schneider T, Bartkowski K, Levkau B, Zeus T, Kelm M, Hohlfeld T, Polzin A.

Pharmacology. 2017;100(3-4):127-130. doi: 10.1159/000477303. Epub 2017 Jun 15.

PMID:
28614821
37.

Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation: reply.

Achilles A, Mohring A, Zeus T, Kelm M, Polzin A.

J Thromb Haemost. 2017 Jul;15(7):1524-1525. doi: 10.1111/jth.13718. Epub 2017 May 30. No abstract available.

38.

Analgesic medication with dipyrone in patients with coronary artery disease: Relation to MACCE.

Achilles A, Mohring A, Dannenberg L, Piayda K, Levkau B, Hohlfeld T, Zeus T, Kelm M, Polzin A.

Int J Cardiol. 2017 Jun 1;236:76-81. doi: 10.1016/j.ijcard.2017.02.122. Epub 2017 Feb 27.

PMID:
28262342
39.

SeQuent Please vs. Pantera Lux drug coated balloon angioplasty in real life: Results from the Düsseldorf DCB registry.

Assadi-Schmidt A, Mohring A, Liebsch E, Dannenberg L, Achilles A, Pöhl M, Afzal S, Veulemans V, Horn P, Sansone R, Bönner F, Levkau B, Kelm M, Zeus T, Polzin A.

Int J Cardiol. 2017 Mar 15;231:68-72. doi: 10.1016/j.ijcard.2016.12.022. Epub 2016 Dec 13.

PMID:
28089147
40.

[Procedures on patients receiving NOACs : What's possible?]

Polzin A, Kelm M, Horn P.

Med Klin Intensivmed Notfmed. 2017 Mar;112(2):117-124. doi: 10.1007/s00063-016-0239-8. Epub 2017 Jan 10. Review. German.

PMID:
28074294
41.

Percutaneous closure of a left atrial appendage with relevant suture dehiscence.

Kleinebrecht L, Veulemans V, Polzin A, Kelm M, Zeus T.

Neth Heart J. 2017 Feb;25(2):152-154. doi: 10.1007/s12471-016-0933-4.

42.

Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation.

Achilles A, Mohring A, Dannenberg L, Grandoch M, Hohlfeld T, Fischer JW, Levkau B, Kelm M, Zeus T, Polzin A.

J Thromb Haemost. 2017 Mar;15(3):473-476. doi: 10.1111/jth.13595. Epub 2017 Feb 6.

43.

Safety and efficacy of transseptal puncture guided by real-time fusion of echocardiography and fluoroscopy.

Afzal S, Veulemans V, Balzer J, Rassaf T, Hellhammer K, Polzin A, Kelm M, Zeus T.

Neth Heart J. 2017 Feb;25(2):131-136. doi: 10.1007/s12471-016-0937-0.

44.

Dipyrone comedication in aspirin treated stroke patients impairs outcome.

Dannenberg L, Erschoff V, Bönner F, Gliem M, Jander S, Levkau B, Kelm M, Hohlfeld T, Zeus T, Polzin A.

Vascul Pharmacol. 2016 Dec;87:66-69. doi: 10.1016/j.vph.2016.06.003. Epub 2016 Jun 11.

PMID:
27301652
45.

On the road: First-in-man bifurcation percutaneous coronary intervention with the use of a dynamic coronary road map and StentBoost Live imaging system.

Dannenberg L, Polzin A, Bullens R, Kelm M, Zeus T.

Int J Cardiol. 2016 Jul 15;215:7-8. doi: 10.1016/j.ijcard.2016.03.133. Epub 2016 Apr 6. No abstract available.

PMID:
27100214
46.

Comparison of Manual and Automated Preprocedural Segmentation Tools to Predict the Annulus Plane Angulation and C-Arm Positioning for Transcatheter Aortic Valve Replacement.

Veulemans V, Zeus T, Kleinebrecht L, Balzer J, Hellhammer K, Polzin A, Horn P, Blehm A, Minol JP, Kröpil P, Westenfeld R, Rassaf T, Lichtenberg A, Kelm M.

PLoS One. 2016 Apr 13;11(4):e0151918. doi: 10.1371/journal.pone.0151918. eCollection 2016.

47.

Loss of Biglycan Enhances Thrombin Generation in Apolipoprotein E-Deficient Mice: Implications for Inflammation and Atherosclerosis.

Grandoch M, Kohlmorgen C, Melchior-Becker A, Feldmann K, Homann S, Müller J, Kiene LS, Zeng-Brouwers J, Schmitz F, Nagy N, Polzin A, Gowert NS, Elvers M, Skroblin P, Yin X, Mayr M, Schaefer L, Tannock LR, Fischer JW.

Arterioscler Thromb Vasc Biol. 2016 May;36(5):e41-50. doi: 10.1161/ATVBAHA.115.306973. Epub 2016 Mar 31.

PMID:
27034473
48.

Troponin T in Prediction of Culprit Lesion Coronary Artery Disease and 1-Year Major Adverse Cerebral and Cardiovascular Events in Patients with Acute Stroke.

Zeus T, Ketterer U, Leuf D, Dannenberg L, Wagstaff R, Bönner F, Gliem M, Jander S, Kelm M, Polzin A.

Transl Stroke Res. 2016 Jun;7(3):180-5. doi: 10.1007/s12975-016-0457-7. Epub 2016 Feb 22.

PMID:
26899027
49.

Antiplatelet effects of aspirin in chronic kidney disease patients.

Polzin A, Dannenberg L, Sansone R, Levkau B, Kelm M, Hohlfeld T, Zeus T.

J Thromb Haemost. 2016 Feb;14(2):375-80. doi: 10.1111/jth.13211. Epub 2016 Jan 25.

50.

Antiplatelet effects of clopidogrel and aspirin after interventional patent foramen ovale/ atrium septum defect closure.

Polzin A, Dannenberg L, Sophia Popp V, Kelm M, Zeus T.

Platelets. 2016 Jun;27(4):317-21. doi: 10.3109/09537104.2015.1096335. Epub 2015 Nov 10.

PMID:
26556101

Supplemental Content

Loading ...
Support Center